Picture of Atlantic International logo

ATLN Atlantic International Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapTurnaround

Momentum

Relative Strength (%)
1m-41.2%
3m-28.59%
6m-61.21%
1yr+426.23%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-93.33%
50d MA-16.9%
200d MA-56.8%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-625.37%
Return on Equity-263.16%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Atlantic International EPS forecast chart

Profile Summary

SeqLL Inc. is an early commercial-stage life sciences instrumentation and research services company. It is engaged in the development of scientific assets and novel intellectual property across multiple omics fields. It designs, develops, and commercializes products and services based on its genetic analysis technologies. It leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid and ribonucleic acid sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform analyse billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with microfluidics and thermal control system to perform sequencing-by-synthesis.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    March 31st, 2024
    Incorporated
    April 3rd, 2014
    Public Since
    August 27th, 2021
    No. of Shareholders
    17
    No. of Employees
    7
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    380,648

    ATLN Share Price Performance

    Upcoming Events for ATLN

    Similar to ATLN

    Picture of Aamaxan Transport logo

    Aamaxan Transport

    us flag iconPink Sheets on Nasdaq

    Picture of ACCUSTEM SCIENCES logo

    ACCUSTEM SCIENCES

    us flag iconPink Sheets on Nasdaq

    Picture of Acutus Medical logo

    Acutus Medical

    us flag iconPink Sheets on Nasdaq

    Picture of ADM Tronics Unlimited logo

    ADM Tronics Unlimited

    us flag iconPink Sheets on Nasdaq

    FAQ